
Indications for Extracorporeal Therapies
Indications for Extracorporeal Therapies

Indications for Extracorporeal Therapies

FloTrac™ cardiac output monitor that uses pulse contour analysis
made by Edwards

Multiple types of face mask are used for personal protection and protection of patient from health care nasopharyngeal secretions

ECMO = extracorporeal membrane oxygenation; used as a supportive strategy in patients who have a high risk of death despite conventional therapy

OVERVIEW Sickle cell disease is caused by HbS haemoglobinopathy which produces rigid, distorted and dysfunctional erythrocytes called sickle cells CAUSE Types of sickle cell disease sickle cell anemia (usually homozygous SS genotype) sickle beta thalassemia sickle HbC disease PRECIPITANTS Commonly:…

Polycythaemia = elevated Hb concentration from either increased RBC mass or decreased plasma volume

Massive Blood Loss

Heparin Induced Thrombotic Thrombocytopaenia Syndrome (HITTS or HIT)

Discrepancies between NIBP and Arterial Pressure

Blood Product Compatibility

Reviewed and revised 11 July 2014 OVERVIEW PATHOPHYSIOLOGY Erythropoiesis RBC lifespan Effects of anaemia Response to anaemia CAUSES Decreased production Increased Destruction Bleeding Haemodilution Laboratory error TYPES OF ANAEMIA MICROCYTIC (MCV <80 fL) NORMOCYTIC (MCV 80-100 fL) Haemolysis MACROCYTIC (>100 fL) This classification…

Haemorrhage is the most important complication of thrombolysis. Intracerebral haemorrhage is especially important with approximately 0.5% risk following STEMI thrombolysis